Lindsay Donohue, PharmD
Dr. Donohue is a graduate of the inaugural class of the University of Virginia division of the Virginia Commonwealth University School of Pharmacy, where she received her PharmD degree in 2014. Prior to attending pharmacy school, she received an undergraduate degree from Virginia Commonwealth University in Communication Arts & Design and worked as a graphic designer for an exhibit design firm. Dr. Donohue will complete a quality improvement project to determine whether patients who experience hypoglycemic events while on subcutaneous insulin are managed according to the institutional hypoglycemic management guidelines. Her longitudinal research project will evaluate the current heart transplant immunosuppression protocol in comparison to both the previous regimen at UVa Medical Center and also to the national average. Outside of work she enjoys spending time with her husband, exploring Charlottesville, and keeping up with her multiple fantasy football teams.
Kelly Lunsford, PharmD
Dr. Lunsford is a graduate of the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, North Carolina, where she earned her PharmD in 2014. Her professional interests include critical care, emergency medicine, and pediatrics. Dr. Lunsford will complete a medication use evaluation to examine ticagrelor to clopidogrel transitions for potential thrombotic events during the index hospitalization, as well as, 30 days post-discharge. Her longitudinal research project will evaluate the use of dexmedetomidine in neonatal and pediatric patients undergoing extracorporeal membrane oxygenation. Upon completion of her PGY1-Pharmacy residency, Dr. Lunsford plans to pursue PGY2 training in critical care or pediatrics. Outside of work she enjoys traveling, wine tasting, and spending time with family.
Andrew Whitman, PharmD
Dr. Whitman received his undergraduate degree in Biology from Christopher Newport University and his PharmD from Virginia Commonwealth University School of Pharmacy. His professional interests are hematology/oncology, pharmacogenomics, and geriatrics. Dr. Whitman will complete a medication use evaluation to review the current management of steroid-induced hyperglycemia in cancer patients. His longitudinal research project will retrospectively look at the incidence of adverse events of asparaginase compared to PEG-asparaginase. Upon completion of his PGY1-Pharmacy residency, Dr. Whitman plans to pursue a PGY2-Oncology residency. Outside of work he enjoys spending time with his wife, Katie, wood carving and reading.
PGY1-Pharmacy/PGY2-Health System Pharmacy Administration Resident
Matthew Allsbrook, PharmD, MS
Dr. Allsbrook completed his pharmacy studies at the University of Michigan College of Pharmacy. His professional interests include the development of specialty pharmacy services and the future impact of biosimilar drug products, both on clinical outcomes as well as health system expenditures. His medication use evaluation will examine whether bivalirudin is used appropriately in patients with HIT/HITTS, according to established guidelines at the UVa Medical Center. Outside of residency, Matthew enjoys rooting for the Michigan Wolverines as well as being a loyal fan of Shaka-nado's havoc basketball team at VCU.
PGY1-Pharmacy/PGY2-Health System Pharmacy Administration Resident
Thomas DiPiro, PharmD, MBA
Dr. DiPiro is a graduate of the South Carolina College of Pharmacy at the Medical University of South Carolina campus, where he earned his PharmD in 2013. He is also a graduate of The Citadel, where he completed his MBA in 2012. His current professional interests include pediatrics and pharmacy services management. Outside of the hospital he follows college football, and roots for the Georgia Bulldogs on Saturdays. He will be completing a quality improvement project assessing adherence to the albumin guideline at the University of Virginia Health System (UVaHS). During his two years at UVaHS he will also complete a Masters in Health System Pharmacy Administration from Virginia Commonwealth University School of Pharmacy.
PGY2-Critical Care Resident
Amanda Liszewski, PharmD
Dr. Liszewski is a graduate of the Duquesne University Mylan School of Pharmacy in Pittsburgh, Pennsylvania, where she earned her PharmD degree in 2013. She completed her PGY1-Pharmacy Residency at the University of Virginia Health System and is excited to have been able to continue her training at UVa for her PGY2-Critical Care Pharmacy Residency. Dr. Liszewski will complete an internal quality project assessing the clinical indications and documentation thereof for broad spectrum antimicrobials in the intensive care units. Her longitudinal research project will evaluate the efficacy and institutional dosing strategies of levetiracetam as first-line urgent therapy in the management of status epilepticus. Upon completion of her PGY2-Critical Care Pharmacy Residency, she plans to pursue a critical care clinical pharmacist position at a tertiary care medical center. Outside of work, she enjoys music, running and cheering on all of her favorite Pittsburgh sports teams.
PGY2-Critical Care Resident
Karen Partlow, PharmD
Dr. Partlow is a graduate of the University of Maryland School of Pharmacy, where she earned her PharmD degree in 2013. She completed her PGY1-Pharmacy residency at the University of Virginia Health System. Dr. Partlow will complete a quality improvement project to evaluate adherence to institutional guidelines for the management of pediatric diabetic ketoacidosis. Her longitudinal research project will examine the use of ketamine as a continuous infusion in critically ill adult patients. Upon completion of her PGY2-critical care pharmacy residency, Dr. Partlow plans to pursue a position as a critical care clinical pharmacist at a large academic medical center. Outside of work she enjoys watching sports (Go Nats and Caps!), cooking, and relaxing with her beagle Hootie.
PGY2-Drug Information Resident
Kara Parsons, PharmD
Dr. Parsons is a graduate of the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, North Carolina, where she earned her PharmD in 2013. She completed her PGY1-Pharmacy residency at Martha Jefferson Hospital in Charlottesville. Dr. Parsons will complete a medication use evaluation to determine the indications for use of nitric oxide in the adult population. Her longitudinal project will involve the development and implementation of an outpatient formulary for UVaHS’s indigent care program. Upon completion of the PGY2-Drug Information pharmacy residency, Dr. Parsons plans to pursue a position in medication use policy, medication safety, or investigational drug services. Outside of work, she enjoys cheering on UVa athletics, playing golf, and curling.
PGY2-Pharmacy Informatics Resident
Sang-weon Lee, PharmD
Dr. Lee is a graduate of Thomas Jefferson University School of Pharmacy in Philadelphia, Pennsylvania, where he earned his PharmD in May 2013. He completed his PGY1-Pharmacy residency at Hahnemann University Hospital in Pennsylvania. Dr. Lee will complete a quality improvement project evaluating the impact of a web-based medication tracking system on the medication distribution process at UVaHS. His longitudinal research project will focus on implementation of barcode scanning technology in sterile pharmacy compounding. Outside of work, he enjoys following sports (Go Blue!), taking photographs, and spending time with his wife.
Lia Lynch, PharmD
Dr. Lynch is a graduate of the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, North Carolina, where she earned her PharmD in 2013. She completed her PGY1-Pharmacy Residency at the University of Virginia Health System. Her professional interests are acute leukemias and their infectious disease complications, supportive care management in solid tumor patients, and benign hematology. Upon completion of the PGY2 program she plans to pursue a clinical oncology specialist position at a comprehensive cancer care center. Dr. Lynch will complete a quality improvement project evaluating voriconazole therapeutic drug monitoring on the hematology/oncology service at UVaHS. Her longitudinal research project will assess hematologic toxicity associated with nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcincoma. Outside of her time spent in the hospital, Lia enjoys spending time with her husband cheering on their favorite team, the NC State Wolfpack, wine tasting in the Virginia countryside, and baking.
Amy Morris, PharmD
Dr. Morris is a 2013 graduate of the University of Georgia College of Pharmacy in Athens, Georgia. She completed her PGY1-Pharmacy residency at the University of Virginia Health System. Her current areas of interest include stem cell transplantation, immunotherapies, and infectious diseases in the immunocompromised host. Amy’s quality improvement project will analyze the incidence of menorrhagia in acute leukemia patients and assess prevention and treatment strategies utilized at UVaHS. Her research project will evaluate empiric antifungal therapy in acute leukemia patients, specifically focusing on patients with relapsed leukemia receiving multiple courses of induction chemotherapy. Upon completion of her PGY2 residency, she plans to pursue a position as an oncology pharmacist at an academic medical center. Amy’s interests outside of pharmacy include horseback riding, traveling, watching football (Go Dawgs!), and spending time with her awesome co-residents.
PGY2-Solid Organ Transplant Resident
Jessica Werth, PharmD
Dr. Werth is a graduate of the University of Kansas, where she earned a B.S. in Organismal Biology in 2008 and her PharmD in 2012. She completed a PGY1-Pharmacy residency at the University of Kansas Hospital in Kansas City, KS in 2013. After working for a year as a clinical pharmacist at Shawnee Mission Medical Center in Shawnee Mission, KS, Dr. Werth decided to return to residency to specialize in solid organ transplant. She is currently completing a research project comparing current and historic liver transplant immunosuppression protocols. For this project, she will investigate renal function outcomes up to 1 year post-transplant when giving basiliximab as an induction immunosuppressant and delaying tacrolimus up to 14 days after transplantation. She is also working on a medication use evaluation to determine the prevalence of venous thromboembolism (VTE) in lung transplant recipients and assess whether appropriate VTE chemoprophylaxis is utilized. Upon completion of her PGY2, she would like to pursue a position as a transplant clinical pharmacist, with the goal of eventually becoming a transplant clinical coordinator. Outside of work, she enjoys Kansas basketball (Rock Chalk!), Jeopardy, copious amounts of coffee, and shopping.